Why Viking Therapeutics Stock Was Victorious This Week

Viking Therapeutics (VKTX 2.85%), a biotech that has shot to prominence thanks to a weight-loss drug it is developing, was a winning stock this week. Over the course of the past five trading days, its price rose by almost 18%, according to data compiled by S&P Global Market Intelligence. It seems a global health agency is ready to support the kinds of medications the company is working on. WHO is backing weight-loss drugs?On Thursday, citing a memo it had reviewed, Reuters reported that no less a body than ...